NextCure (NXTC) Cash & Equivalents (2018 - 2026)
NextCure (NXTC) reported Cash & Equivalents of $15.26 million for Q2 2026, up 211.9% from $4.89 million a year earlier and up 0.6% from the prior quarter.
Powered by 
Analysis
NextCure (NXTC) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, NextCure posted Cash & Equivalents of $25.98 million, down 6.3% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $27.73 million in FY2024 (+111.9%), $13.08 million in FY2023 (-50.9%), $26.63 million in FY2022 (+115.9%) and $12.34 million in FY2021 (-62.4%).
- Five-year quarterly Cash & Equivalents spans a low of $4.89 million in Q2 2025 and a high of $36.66 million in Q3 2021.
- Year over year, Cash & Equivalents gained in four of the last eight quarters, with growth averaging 24.7%.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2026 (growth of 211.9%); the low point was Q2 2025 (a decline of 76.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $15.17 million (Q1 2026), $25.98 million (Q4 2025) and $7.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | NextCure | 26.02 Mn | -94.74 Mn | - | 15.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.26 Mn |
| Mar 31, 2026 | 15.17 Mn |
| Dec 31, 2025 | 25.98 Mn |
| Sep 30, 2025 | 7.32 Mn |
| Jun 30, 2025 | 4.89 Mn |
| Mar 31, 2025 | 21.83 Mn |
| Dec 31, 2024 | 27.73 Mn |
| Sep 30, 2024 | 27.70 Mn |
| Jun 30, 2024 | 20.85 Mn |
| Mar 31, 2024 | 18.36 Mn |
| Dec 31, 2023 | 13.08 Mn |
| Sep 30, 2023 | 19.52 Mn |
| Jun 30, 2023 | 22.02 Mn |
| Mar 31, 2023 | 29.97 Mn |
| Dec 31, 2022 | 26.63 Mn |
| Sep 30, 2022 | 31.05 Mn |
| Jun 30, 2022 | 28.16 Mn |
| Mar 31, 2022 | 10.65 Mn |
| Dec 31, 2021 | 12.34 Mn |
| Sep 30, 2021 | 36.66 Mn |
API Access
NextCure Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();